These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 14126560)

  • 1. PROGRESS ON INVESTIGATIONAL DRUGS.
    RANKIN WB
    SD J Med Pharm; 1964 Mar; 17():42-5. PubMed ID: 14126560
    [No Abstract]   [Full Text] [Related]  

  • 2. CONTROL EXPERIENCE WITH INVESTIGATIONAL NEW DRUGS.
    MEYERS EL
    Bull Parenter Drug Assoc; 1963; 17():27-37. PubMed ID: 14083963
    [No Abstract]   [Full Text] [Related]  

  • 3. THE INVESTIGATIONAL DRUG BRANCH: A REVIEW OF OBJECTIVES AND FUNCTION.
    KELSEY FO
    J New Drugs; 1963; 3(4):250-5. PubMed ID: 14063363
    [No Abstract]   [Full Text] [Related]  

  • 4. The food and Drug Administration's view of investigational drugs.
    MEYERS EL
    SD J Med Pharm; 1963 Jul; 16():40-6. PubMed ID: 13935340
    [No Abstract]   [Full Text] [Related]  

  • 5. PROGRESS ON INVESTIGATIONAL DRUGS.
    RANKIN WB
    J New Drugs; 1963; 3(6):377-80. PubMed ID: 14113562
    [No Abstract]   [Full Text] [Related]  

  • 6. INVESTIGATIONAL DRUG REGULATIONS AND CLINICAL RESEARCH.
    GIBSON ML
    J Oral Ther Pharmacol; 1964 Jul; 1():93-8. PubMed ID: 14204421
    [No Abstract]   [Full Text] [Related]  

  • 7. [RESPONSIBILITY OF THE PHYSICIAN IN THE ADMINISTRATION OF NEW DRUGS (INVESTIGATIONAL PREPARATIONS, PARTICULARLY UNREGISTERED DRUGS)].
    KOHLHAAS M
    Munch Med Wochenschr; 1964 Dec; 106():2281-8. PubMed ID: 14336570
    [No Abstract]   [Full Text] [Related]  

  • 8. Liability in use of investigational drugs.
    SCHREINER GE
    JAMA; 1963 Jul; 185():259-63. PubMed ID: 13987033
    [No Abstract]   [Full Text] [Related]  

  • 9. Proving ground for tomorrow's drugs.
    HUNT MM; WOLTERS D
    Sci Illus; 1948 Aug; 3(8):17-23. PubMed ID: 18880995
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of investigational drugs in hospitals; a survey. I.
    TEPLITSKY B
    Hosp Prog; 1956 Aug; 37(8):76-82. PubMed ID: 13345319
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of investigational drugs in hospitals; a survey. II.
    TEPLITSKY B
    Hosp Prog; 1956 Sep; 37(9):106; passim. PubMed ID: 13357155
    [No Abstract]   [Full Text] [Related]  

  • 12. Problems relating to investigational drugs.
    KELSEY FO
    J New Drugs; 1963; 3():71-4. PubMed ID: 14031846
    [No Abstract]   [Full Text] [Related]  

  • 13. [THE RISK OF POISONING IN THE USE OF DRUGS].
    BARNES JM
    Sven Farm Tidskr; 1963 Sep; 67():739-47. PubMed ID: 14087146
    [No Abstract]   [Full Text] [Related]  

  • 14. RESPONSIBILITY FOR TESTING DRUGS IN HUMANS.
    DOWLING HF
    JAMA; 1964 Jan; 187():212-5. PubMed ID: 14067988
    [No Abstract]   [Full Text] [Related]  

  • 15. THE NEW food and drugs legislation.
    Public Health; 1956 Feb; 69(5):96-7; passim. PubMed ID: 13310720
    [No Abstract]   [Full Text] [Related]  

  • 16. RULES, REGULATIONS AND RESEARCH.
    NEIBEL OJ
    New Physician; 1963 Dec; 12():A85-A87. PubMed ID: 14103668
    [No Abstract]   [Full Text] [Related]  

  • 17. [The 1990 drug law. Its implications for the clinical doctor].
    Castillo Pérez P; Gutiérrez López JF
    Med Clin (Barc); 1992 Feb; 98(7):263-9. PubMed ID: 1560703
    [No Abstract]   [Full Text] [Related]  

  • 18. MALPRACTICE AND ASSAULT AND THE DRUG AMENDMENTS OF 1962.
    LEVIN M
    Mil Med; 1964 Nov; 129():1036-9. PubMed ID: 14200846
    [No Abstract]   [Full Text] [Related]  

  • 19. [The Contribution of GMP-grade Hospital Preparation to Translational Research].
    Yonezawa A; Kajiwara M; Minami I; Omura T; Nakagawa S; Matsubara K
    Yakugaku Zasshi; 2015; 135(8):943-7. PubMed ID: 26234351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. THE PHYSICIAN AS FINAL ARBITER?
    PAGE I
    Appl Ther; 1964 Apr; 6():293-5. PubMed ID: 14152073
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.